Articles/Muscle Soreness Hypertrophy: Does DOMS Mean Growth?

Muscle Soreness Hypertrophy: Does DOMS Mean Growth?

By Lyfta · 10 min read · September 8, 2026

Muscle soreness hypertrophy questions usually sound like gym folklore: if you are not limping after a session, did you even train hard enough? Delayed-onset muscle soreness (DOMS) is real, uncomfortable, and common after novel or eccentric-heavy work — but it is a poor scoreboard for muscle growth. Reviews of exercise-induced muscle damage (EIMD) and hypertrophy treat damage as a possible companion of hard training, not a required growth signal (Schoenfeld, 2012).

This article separates DOMS from progress. You will see why early “size” jumps can be swelling, why myofibrillar protein synthesis tracks hypertrophy better once damage settles, and how to program without chasing pain. For weekly set targets once you stop using soreness as feedback, see sets per week for hypertrophy.

What DOMS is — and what it is not

DOMS is the delayed ache that peaks about 24–72 hours after unaccustomed or high-eccentric training. Classic sports-medicine reviews describe it as a multifactorial syndrome tied to microtrauma, inflammation, and altered sensation — not a simple “fibers tore, therefore they will grow” switch (Cheung, Hume, & Maxwell, 2003). Soreness can show up after a productive session, a poorly recovered session, or a first exposure to a new exercise with little lasting hypertrophy benefit.

Pain is also not the same as useful mechanical tension. Hypertrophy reviews emphasize tension, metabolic stress, and other sensors as candidate drivers; muscle damage is discussed as a possible contributor or byproduct, not the master key (Wackerhage et al., 2019; Schoenfeld, 2012). If your plan already covers progressive load, enough hard sets, and recovery, adding more DOMS on purpose is usually noise — not a missing ingredient.

Muscle damage is not required for growth

Schoenfeld’s narrative review on EIMD and hypertrophy concludes that while damage can accompany effective training, the evidence does not show that you must damage muscle to grow it. Mechanisms that support hypertrophy can operate without maximizing soreness, and excessive damage may impair subsequent performance and volume quality (Schoenfeld, 2012).

Flann and colleagues tested the “no pain, no gain” idea directly: one group gradually ramped eccentric loading to minimize markers of damage, while another used a more damaging introduction. Both groups increased muscle size similarly when the training stimulus was otherwise matched — arguing that remodeling does not require a large damage spike (Flann, LaStayo, McClain, Hazel, & Lindstedt, 2011). Treat that as strong mechanistic evidence against chasing DOMS, not as a claim that every protocol is identical.

A later review by Damas, Libardi, and Ugrinowitsch synthesizes damage, protein synthesis, and hypertrophy: early training weeks often show high muscle damage and elevated protein synthesis that does not yet map cleanly onto lasting fiber growth. As sessions become familiar, damage markers fall and the relationship between myofibrillar synthesis and hypertrophy becomes clearer (Damas, Libardi, & Ugrinowitsch, 2018). In plain language: the soreness-heavy “first two weeks of a new split” are a poor proxy for long-term gains.

Early “growth” can be swelling, not muscle

First-week jumps in muscle cross-sectional area can partly reflect edema-related swelling after damaging sessions, not pure contractile tissue accrual (Damas et al., 2016a). That matters if you use a tape measure or mirror after a brutal novel workout and conclude the program “works” because everything feels pumped and sore.

In a key time-course study, integrated myofibrillar protein synthesis related to hypertrophy only after muscle damage had attenuated — early synthesis elevations during the most damaging phase did not predict growth the way later, lower-damage weeks did (Damas et al., 2016b). So when DOMS is loudest, your body is often still prioritizing repair and remodeling noise; judge the program after familiarization, not after the first painful session.

Athlete squatting calmly beside a floating card comparing a puffy edema-like muscle cross-section to a denser growth cross-section

Read the floating comparison as a teaching metaphor: early post-damage “size” can look like progress while still reflecting swelling more than new contractile tissue.

A practical template that ignores soreness as a scoreboard

Use this for 4–8 weeks. Progress load or reps under progressive overload; keep rest periods long enough to protect hard-set quality on compounds.

  1. Pick a stable exercise menu — squat or leg press, hinge, horizontal push, horizontal pull, plus 1–2 accessories. Changing everything every week keeps DOMS high and learning low.
  2. Target weekly hard sets — roughly 10–20 hard sets per major muscle across the week for most intermediates, adjusted for recovery (see the sets-per-week guide).
  3. Leave 0–3 reps in reserve on most working sets — high effort without inventing extra damage via endless failure on every lift (training to failure, RPE).
  4. Introduce new exercises with a ramp week — one lighter familiarization session before full volume reduces unnecessary DOMS without cutting long-term stimulus (consistent with Flann et al., 2011 and Damas et al., 2018).
  5. Judge progress on performance and trend — reps at a given load, weekly set completion, and multi-week size or strength trends — not next-day pain. Track sessions in Lyfta so soreness notes stay optional context beside load and set counts.

Example lower day after familiarization: back squat 3×6–8, Romanian deadlift 3×8–10, leg press 2×10–12, calf raise 2×10–15. Expect less DOMS by week 3 of the same layout even when loads rise — that is adaptation, not “going soft.” Browse movement options in the exercise library if you need substitutions that keep joint-friendly tension without novelty for novelty’s sake.

Athlete logging a workout on a phone beside icons for a stable training plan and a crossed-out pain motif

Keep the scoreboard on load, reps, and completed hard sets. Optional soreness notes are context — not the goal of the session.

Common mistakes

  • Chasing DOMS with constant exercise swaps — novelty raises soreness and can cut the quality of progressive overload on skilled lifts.
  • Reading first-week girth as muscle — early CSA changes can include edema; wait for calmer weeks before celebrating (Damas et al., 2016a).
  • Equating “no soreness” with “no stimulus” — trained muscles often stop getting very sore while still growing if tension and volume progress (Schoenfeld, 2012; Damas et al., 2018).
  • Stacking damage on poor sleep — when readiness is low, more eccentric novelty is usually the wrong lever; fix recovery first (sleep and recovery).
  • Skipping deloads because you “don’t feel broken” — planned lighter weeks manage fatigue even when DOMS is mild (deload weeks).

When soreness still deserves attention

Mild-to-moderate DOMS after a planned hard block or travel-related layoff is usually fine. Sharp joint pain, swelling that does not improve, or performance that collapses for days is not “good sore” — reduce load, check technique, and seek clinical care when pain patterns look like injury rather than typical muscle ache (Cheung et al., 2003). This article is training education, not medical advice.

Also keep eccentric-focused blocks and lengthened-position work purposeful. Those tools can raise DOMS and still be useful for specific goals when volume is controlled — see eccentric training and range of motion — but the pain itself remains a side effect, not the target.

Bottom line

Muscle soreness hypertrophy myths collapse under the evidence: DOMS reflects novelty and damage more than long-term growth. Matched-stimulus work can grow muscle with less damage; early swelling can masquerade as size; and protein synthesis aligns with hypertrophy more cleanly after damage settles. Train for progressive tension and recoverable weekly sets, not for limping tomorrow. For more evidence-based guides, browse all Lyfta articles or start from the Lyfta home page.

References

  1. Schoenfeld, B. J. (2012). Does exercise-induced muscle damage play a role in skeletal muscle hypertrophy? Journal of Strength and Conditioning Research, 26(5), 1441–1453. https://doi.org/10.1519/JSC.0b013e31824f207e · PubMed 22344059
  2. Damas, F., Phillips, S. M., Libardi, C. A., Vechin, F. C., Lixandrão, M. E., Jannig, P. R., Costa, L. A., Bacurau, A. V., Snijders, T., Parise, G., Tricoli, V., Roschel, H., & Ugrinowitsch, C. (2016). Resistance training-induced changes in integrated myofibrillar protein synthesis are related to hypertrophy only after attenuation of muscle damage. The Journal of Physiology, 594(18), 5209–5222. https://doi.org/10.1113/JP272472 · PubMed 27219125 · PMC5023708
  3. Damas, F., Libardi, C. A., & Ugrinowitsch, C. (2018). The development of skeletal muscle hypertrophy through resistance training: the role of muscle damage and muscle protein synthesis. European Journal of Applied Physiology, 118(3), 485–500. https://doi.org/10.1007/s00421-017-3792-9 · PubMed 29282529
  4. Flann, K. L., LaStayo, P. C., McClain, D. A., Hazel, M., & Lindstedt, S. L. (2011). Muscle damage and muscle remodeling: no pain, no gain? The Journal of Experimental Biology, 214(Pt 4), 674–679. https://doi.org/10.1242/jeb.050112 · PubMed 21270317
  5. Damas, F., Phillips, S. M., Lixandrão, M. E., Vechin, F. C., Libardi, C. A., Roschel, H., Tricoli, V., & Ugrinowitsch, C. (2016). Early resistance training-induced increases in muscle cross-sectional area are concomitant with edema-induced muscle swelling. European Journal of Applied Physiology, 116(1), 49–56. https://doi.org/10.1007/s00421-015-3243-4 · PubMed 26280652
  6. Wackerhage, H., Schoenfeld, B. J., Hamilton, D. L., Lehti, M., & Hulmi, J. J. (2019). Stimuli and sensors that initiate skeletal muscle hypertrophy following resistance exercise. Journal of Applied Physiology, 126(1), 30–43. https://doi.org/10.1152/japplphysiol.00685.2018 · PubMed 30335577
  7. Cheung, K., Hume, P., & Maxwell, L. (2003). Delayed onset muscle soreness: treatment strategies and performance factors. Sports Medicine, 33(2), 145–164. https://doi.org/10.2165/00007256-200333020-00005 · PubMed 12617692